-
公开(公告)号:EP3368515B1
公开(公告)日:2019-07-17
申请号:EP16791511.5
申请日:2016-10-27
申请人: Inception 3, Inc.
IPC分类号: C07D223/20 , A61P27/16 , A61K9/00 , A61K47/02 , C07D223/18 , A61K47/10 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38
-
公开(公告)号:EP3368515A1
公开(公告)日:2018-09-05
申请号:EP16791511.5
申请日:2016-10-27
申请人: Inception 3, Inc.
IPC分类号: C07D223/18 , A61K31/55
CPC分类号: C07D223/20 , A61K9/0046 , A61K47/02 , A61K47/10 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38 , A61P27/16 , C07B2200/13 , C07D223/18
摘要: The present disclosure provides crystalline Compound I and crystalline Compound II, pharmaceutical compositions comprising one of said crystalline compounds suitable for intratympanic administration, and methods for treating otic disorders using the crystalline compounds and the pharmaceutical compositions.
-